WR Wealth Planners’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$127 Hold
8
﹤0.01% 1074
2024
Q3
$192 Hold
8
﹤0.01% 1104
2024
Q2
$159 Hold
8
﹤0.01% 1107
2024
Q1
$159 Buy
+8
New +$155 ﹤0.01% 1136
2023
Q4
Sell
-8
Closed -$162 231
2023
Q3
$162 Hold
8
﹤0.01% 883
2023
Q2
$204 Hold
8
﹤0.01% 869
2023
Q1
$238 Hold
8
﹤0.01% 886
2022
Q4
$216 Hold
8
﹤0.01% 473
2022
Q3
$174 Hold
8
﹤0.01% 493
2022
Q2
$219 Hold
8
﹤0.01% 505
2022
Q1
$268 Buy
+8
New +$258 ﹤0.01% 498

Other funds holding AVNS

WR Wealth Planners's AVNS Position: Q4 2024 in Review

WR Wealth Planners held its Avanos Medical (AVNS) position steady in Q4 2024 at 8 shares worth $127. The position accounts for ﹤0.01% of the portfolio, ranked #1074.

WR Wealth Planners first reported a position in AVNS in Q1 2022 and has held it in 11 quarters since. The position peaked at $268 in Q1 2022. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

  • WR Wealth Planners held 8 shares of Avanos Medical worth $127 as of Q4 2024.
  • WR Wealth Planners left its Avanos Medical share count unchanged in Q4 2024.
  • Avanos Medical made up ﹤0.01% of WR Wealth Planners's portfolio in Q4 2024, its #1074 holding.
  • WR Wealth Planners first reported a position in Avanos Medical in Q1 2022 and has held it in 11 quarters since.
  • WR Wealth Planners's Avanos Medical position peaked at $268 in Q1 2022.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.